Duopharma Biotech Berhad (KLSE:DPHARMA)

Market Cap	1.28B +12.7%
Revenue (ttm)	931.69M +14.5%
Net Income	87.46M +39.6%
EPS	0.09 +39.6%
Shares Out	961.94M
PE Ratio	14.63
Forward PE	12.64
Dividend	0.05 (3.50%)
Ex-Dividend Date	Mar 12, 2026

Volume	733,100
Average Volume	600,405
Open	1.300
Previous Close	1.300
Day's Range	1.290 - 1.360
52-Week Range	1.070 - 1.570
Beta	0.47
RSI	48.25
Earnings Date	May 15, 2026

About Duopharma Biotech Berhad

Duopharma Biotech Berhad, an investment holding company, researches, develops, manufactures, distributes, and imports pharmaceutical products and medicines in Malaysia and internationally. The company offers consumer healthcare products, such as vitamins, minerals, and supplements, analgesics, eyecare, antacids, and skin care products; and generic drugs for various therapeutic classes, such as cardiovascular, dermatology, hormones, respiratory, sensory and nervous system, musculo-skeletal system, anti-infectives, and others. It also provides sp...

• Industry: Pharmaceutical Preparations
• Founded: 1978
• Employees: 1,957
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: DPHARMA

Financial Performance

In 2025, Duopharma Biotech Berhad's revenue was 931.69 million, an increase of 14.50% compared to the previous year's 813.70 million. Earnings were 87.46 million, an increase of 39.62%.